Chad Haldeman Englert, MD
Clinical Genetics (M.D.) · Greensboro, NCNPI 1013109594
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $10,318 of the $12,410 with a category attached, or 83.1%. Sanofi accounts for 97.3% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2023 at $9,991 and has fallen 98.1% since, to $186 in 2025.
Across 30 payments — averaging $413.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$12K
- Illumina, Inc.$123
- Amicus Therapeutics, Inc.$102
- Biomarin Pharmaceutical Inc.$30
- Chiesi USA, Inc.$25
- Acadia Pharmaceuticals Inc$22
- plus $28 from 2 others
What the payments were for
- Consulting fees$10,31883%
- Travel & lodging$1,1299%
- Food & beverage$8467%
- Education$1171%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 17 | $12,080 |
| Illumina, Inc. | 1 | $123 |
| Amicus Therapeutics, Inc. | 2 | $102 |
| Biomarin Pharmaceutical Inc. | 1 | $30 |
| Chiesi USA, Inc. | 1 | $25 |
| Acadia Pharmaceuticals Inc | 1 | $22 |
| Travere Therapeutics, Inc. | 6 | $17 |
| Biogen | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LUMIZYME$7,994
- FABRAZYME$1,906
- Genetic Disease Testing$123
How this compares
Too few clinical genetics (m.d.) providers in North Carolinato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other clinical genetics (m.d.) in Greensboro
- Rose GuoGreensboro$618
- Dmitriy NiyazovDurham$331K
- Susan SparksCharlotte$17K
- Areeg El-GharbawyDurham$5K
- Laurie DemmerCharlotte$117
- Lauren CarterCharlotte$50
- Vandana ShashiDurham$17
- Karen SchmidtGreenville$12
- Margie JaworskiGreenville$12
- Tamison JewettWinston Salem$2
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.